Allikaloend
5 Gissler M, Fronteira I, Jahn A, Karro H, Moreau C, da Silva MO et al. Terminations of pregnancy in the European Union. Br J Obstet Gynaecol 2012;119:324–32.
6 Laanpere M, Ringmets I, Part K, et al. Induced abortion trends from 1996 to 2011 in Estonia: special emphasis on repeat abortion. BMC Womens Health 2014;14:81.
7 Haldre K, Part K, Ketting E. Youth sexual health improvement in Estonia, 1990–2009: The role of sexuality education and youth-friendly services. Eur J Contracep Repr 2012; 7:351–6.
13 Raymond EG, Grimes DA. The comparative safety of legal induced abortion and childbirth in the United States. Obstet Gynecol 2012;119:215-9.
14 Say L, Brahmi D, Kulier R, Campana A, Gülmezoglu AM. Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database Syst Rev 2005;(1):CD003037.
15 Niinimäki M, Pouta A, Bloigu A, Gissler M, Hemminki E, Suhonen S, et al. Immediate complications after medical compared with surgical termination of pregnancy. Obstet Gynecol 2009;114:795–804.
16 Kaunitz AM, Rovira EZ, Grimes DA, Schulz KF. Abortions that fail. Obstet Gynecol 1985;66:533–7.
17 Bygdeman M, Danielsson KG. Options for early therapeutic abortion. A comparative review. Hum Reprod Update 2007;13:37–52.
19 Heisterberg L, Hebjorn S, Andersen LF, Petersen H. Sequelae of induced first-trimester abortion. A prospective study assessing the role of postabortal pelvic inflammatory disease and prophylactic antibiotics. Am J Obstet Gynecol 1986;155:76-80.
21 Klemetti R, Gissler M, Niinimaki M, Hemminki E. Birth outcomes after induced abortion: a nationwide register-based study of first births in Finland. Human Reproduction 2012;27:3315–20.
23 Lohr PA, Fjerstad M, DeSilva U, Lyus R. Abortion – clinical review. BMJ 2014;348:f7553.
24 Low N, Mueller M, Van Vliet HAAM, Kapp N. Antibiotic prophylaxis for medical and surgical first-trimester induced abortion. Review by the Cochrane Collaboration.The Cochrane Library 2012, Issue 3.
25 Achilles SL, Reeves MF; Society of Family Planning. Prevention of infection after induced abortion: release date October 2010: SFP Guideline 20102. Contraception 2011;83:295–309.
26 World Health Organization. Medical eligibility criteria for contraceptive use. Geneva: WHO, 2015.
27 Kapp N, Lohr PA, Ngo TD, Hayes JL. Cervical preparation for first trimester surgical
abortion. Cochrane Database Syst Rev 2010;2:CD007207.
abortion. Cochrane Database Syst Rev 2010;2:CD007207.
29 Bartley J, Tong S, Everington D ym. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000;62:297-303.
30 Ashok PW, Templeton A, Wagaarachchi PT ym. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG 2002;109:1281‒9.
31 von Hertzen H, Honkanen H, PiaggioG, Bartfai G, Erdenetungalag R, Gemzell-Danielsson et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. BJOG 2003; 110: 808‒18.
34 Ngo TD, Park MH, Shakur H, Free C. Comparative effectiveness, safety and acceptability
of medical abortion at home and in a clinic: a systematic review. Bull World Health Organ
2011;89:360-70.
of medical abortion at home and in a clinic: a systematic review. Bull World Health Organ
2011;89:360-70.
35 Fiala C, Fux M, Gemzell DK. Rh-prophylaxis in early abortion. AOGS 2003;82:892–903.
36 Fiala C, Gemzell-Danielsson K. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception 2006;74:66–8.
37 Wolman I, Altman E, Faith G, Har-Toov J, Amster R, Gull I, Jaffa AJ. Combined clinical and ultrasonographic work-up for the diagnosis of retained products of conception. Fertil Steril 2009;92:1162–4.
38 Oppegaard K, Qvigstad E, Sunde K, Fiala C, Heikinheimo O, Benson L, Gemzell-Danielsson K. Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial. Lancet Glob Health 2015;3:e537‒45.
39 Cameron ST, Glasier A, Dewart H, Johnstone A, Burnside A. Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: a service evaluation. Contraception 2012;86:67–73.
40 Michie L, Cameron ST. Simplified follow-up after early medical abortion: 12-month experience of a telephone call and self-perfomed low-sensitivity urine pregnancy test. Contraception 2014;89:440–45.
41 Reeves MF, Kudva A, Creinin MD. Medical abortion outcomes after a second dose of
misoprostol for persistent gestational sac. Contraception 2008;78:332-5.
misoprostol for persistent gestational sac. Contraception 2008;78:332-5.
42 Cameron IT, Baird DT. The return to ovulation following early abortion: a comparison between vacuum aspiration and prostaglandin. Acta Endocrinol 1988;118:161–7.
43 Royal College of Obstetricians and Gynaecologists. Faculty of Sexual and Reproductive Healthcare Clinical Guidance Quick Starting Contraception Clinical Effectiveness Unit. RCOG; London, 2010.
44 Gaffield ME, Kapp N, Ravi A. Use of combined oral contraceptives post abortion. Contraception 2009;80:355–62.
